Patents by Inventor Hidenori Funamizu

Hidenori Funamizu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • N-Acylated lipophilic amino acid derivatives
    Publication number: 20080027038
    Abstract: Compounds of structural formula (I) where A is a lipophilic group including an aliphatic bridging group, B is a lipophilic group, D is a group having at least one amino or substituted amino group and R is hydrogen, alkyl or cycloalkyl, and pharmaceutically acceptable salts and individual isomers thereof, which have growth hormone releasing activity in humans or animals.
    Type: Application
    Filed: August 20, 2007
    Publication date: January 31, 2008
    Applicants: Kaken Pharmaceutical Co., Ltd., Molecular Research Institute
    Inventors: HIdenori Funamizu, Nobuo Ishiyama, Satoru Ikegami, Tadashi Okumo, Kiyoshi Inoguchi, Ping Huang, Gilda Loew
  • Amide derivatives
    Patent number: 7279573
    Abstract: Compounds of structural Formula (I) where A is a lipophilic group including an aliphatic bridging group, B is a lipophilic group, D is a group having at least one amino or substituted amino group and R is hydrogen, alkyl or cycloalkyl, and pharmaceutically acceptable salts and individual isomers thereof, which have growth hormone releasing activity in humans or animals
    Type: Grant
    Filed: February 23, 2006
    Date of Patent: October 9, 2007
    Assignees: Kaken Pharmaceutical Co., Ltd., Molecular Research Institute
    Inventors: Hidenori Funamizu, Nobuo Ishiyama, Satoru Ikegami, Tadashi Okuno, Kiyoshi Inoguchi, Ping Huang, Gilda Loew
  • Novel amide derivatives
    Publication number: 20060142264
    Abstract: Compounds of structural Formula (I) where A is a lipophilic group including an aliphatic bridging group, B is a lipophilic group, D is a group having at least one amino or substituted amino group and R is hydrogen, alkyl or cycloalkyl, and pharmaceutically acceptable salts and individual isomers thereof, which have growth hormone releasing activity in humans or animals.
    Type: Application
    Filed: February 23, 2006
    Publication date: June 29, 2006
    Applicants: Kaken Pharmaceutical Co., Ltd., Molecular Research Institute
    Inventors: Hidenori Funamizu, Nobuo Ishiyama, Satoru Ikegami, Tadashi Okuno, Kiyoshi Inoguchi, Ping Huang, Gilda Loew
  • N-acylated lipophilic amino acid derivatives
    Patent number: 7064121
    Abstract: Compounds of structural Formula (I) where A is a lipophilic group including an aliphatic bridging group, B is a lipophilic group, D is a group having at least one amino or substituted amino group and R is hydrogen, alkyl or cycloalkyl, and pharmaceutically acceptable salts and individual isomers thereof, which have growth hormone releasing activity in humans or animals
    Type: Grant
    Filed: October 13, 2004
    Date of Patent: June 20, 2006
    Assignees: Kaken Pharmaceutical Co., Ltd., Molecular Research Institute
    Inventors: Hidenori Funamizu, Nobuo Ishiyama, Satoru Ikegami, Tadashi Okuno, Kiyoshi Inoguchi, Ping Huang, Gilda Loew
  • N-acylated lipophilic amino acid derivatives
    Publication number: 20050059699
    Abstract: Compounds of structural Formula (I) where A is a lipophilic group including an aliphatic bridging group, B is a lipophilic group, D is a group having at least one amino or substituted amino group and R is hydrogen, alkyl or cycloalkyl, and pharmaceutically acceptable salts and individual isomers thereof, which have growth hormone releasing activity in humans or animals.
    Type: Application
    Filed: October 13, 2004
    Publication date: March 17, 2005
    Applicants: Kaken Pharmaceutical Co., Ltd., Molecular Research Institute
    Inventors: Hidenori Funamizu, Nobuo Ishiyama, Satoru Ikegami, Tadashi Okuno, Kiyoshi Inoguchi, Ping Huang, Gilda Loew
  • N-acylated lipophilic amino acid derivatives
    Patent number: 6864250
    Abstract: Compounds of structural Formula (I) where A is a lipophilic group including an aliphatic bridging group, B is a lipophilic group, D is a group having at least one amino or substituted amino group and R is hydrogen, alkyl or cycloalkyl, and pharmaceutically acceptable salts and individual isomers thereof, which have growth hormone releasing activity in humans or animals
    Type: Grant
    Filed: August 20, 1998
    Date of Patent: March 8, 2005
    Assignees: Kaken Pharmaceutical Co., Ltd., Molecular Research Institute
    Inventors: Hidenori Funamizu, Nobuo Ishiyama, Satoru Ikegami, Tadashi Okuno, Kiyoshi Inoguchi, Ping Huang, Gilda Loew